Microglia Potentiate Damage to Blood–Brain Barrier Constituents

junio 27, 2007 at 9:19 pm Deja un comentario


Background— Blood–brain barrier (BBB) disruption after stroke can worsen ischemic injury by increasing edema and causing hemorrhage. We determined the effect of microglia on the BBB and its primary constituents, endothelial cells (ECs) and astrocytes, after ischemia using in vivo and in vitro models. Methods and Results— Primary astrocytes, ECs, or cocultures were prepared with or without added microglia. Primary ECs were more resistant to oxygen-glucose deprivation/reperfusion than astrocytes. ECs plus astrocytes showed intermediate vulnerability. Microglia added to cocultures nearly doubled cell death. This increase was prevented by minocycline and apocynin. In vivo, minocycline reduced infarct volume and neurological deficits and markedly reduced BBB disruption and hemorrhage in mice after experimental stroke.

Conclusions— Inhibition of microglial activation may protect the brain after ischemic stroke by improving BBB viability and integrity. Microglial inhibitors may prove to be an important treatment adjunct to fibrinolysis.
Key Words: blood–brain barrier • inflammation • ischemia • microglia

After stroke, a disrupted blood–brain barrier (BBB) can lead to edema, hemorrhage, and transmigration of leukocytes and large toxic molecules into the brain. The BBB consists of endothelial cells (ECs) surrounded by astrocytes. Microglia, considered the resident immune cells of the brain, are also associated with the BBB and are among the first cells to respond to threats to the brain.1,2 When activated, microglia undergo proliferation, chemotaxis, morphological alterations, and generate immunomodulatory molecules. Microglia release proteases, lipases, and glutamate3,4 and are sensitive to hypoxia- and ischemia-like insults in vitro with a vulnerability greater than oligodendrocytes5 and similar to or less than astrocytes,6 depending on the model and species used. Their role in maintaining or interfering with BBB integrity in the context of ischemia is not well studied. Blocking microglial activation may limit BBB disruption and reduce edema and hemorrhagic transformation.

Superoxide is involved in lipid peroxidation, protein oxidation, and DNA damage. Leukocytes and microglia generate superoxide via the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase system.7 ECs also generate reactive oxygen species. Xu et al8 found that inducible NO synthase, NO, and peroxynitrite were increased in bovine ECs after oxygen-glucose deprivation (OGD). Here we show that addition of microglia to ECs and astrocyte cocultures worsens ischemia-like injury, and inhibiting microglial activation with minocycline or inhibiting superoxide production by NADPH oxidase with apocynin preserves BBB constituents in vitro and reduces BBB disruption and hemorrhage in vivo.

* Methods

Cell Culture
Primary cerebral microvascular EC cultures were prepared from young mouse brains.9 Gray matter from 3- to 4-week-old mice was homogenized in calcium and magnesium free Hank’s balanced salt solution (BSS) containing 0.35% collagenase and 0.2% BSA for 2.5 hours at 37°C. Tissue was resuspended in 25% BSA, then centrifuged at 4°C for 20 minutes at 528g. This pellet containing brain capillaries was incubated in 0.1% collagenase/dispase in bicarbonate containing M199 media (Gibco BRL; 11150-059) for 2 hours at 37°C to remove pericytes. The cells were pelleted, resuspended, then centrifuged on a Percoll gradient (11 mL Percoll in 21 mL Earl’s BSS) at 733g for 10 minutes at 4°C. The capillary microvessel EC layer was collected, washed in M199 media, and plated on collagen-coated plates at 106 cells/mL in E-STIM EC culture media (Becton Dickinson) supplemented with 10 ng/mL epidermal growth factor plus penicillin/streptomycin (100 U/mL). Cultures were fed every 3 days, subcultured after 2 weeks at &80% confluence, and used after 3 to 4 passages.

Neocortical astrocytes were isolated from postnatal day 1 or 2 Swiss Webster mice (Simonsen [Gilroy, Calif] or Charles River [Wilmington, Mass])10 and used for experiments 3 weeks later. Microglia were isolated by shaking off from mixed glial cultures as described previously,6 plated at 1 to 3x105 cells/mL, and used for experiments 24 hours after plating. ECs or astrocytes were seeded at 106 cells/mL when used alone or 0.5x106 cells/mL in EC/astrocyte (EA) cocultures. Cocultures were grown in 50% EC and 50% astrocyte medium and were used for experiments 2 to 4 days later. For tricultures (EC/astrocyte/microglia [EAM]), microglia were seeded onto cocultures at a density of 105 cells/mL and were allowed to stabilize on top of cocultures for 1 day before use.

OGD and Analysis
Cultures were subjected to OGD in BSS in an anoxic chamber (Coy Laboratories) with O2 tension <0.02%.11 About 4- to 6-hour OGD for astrocytes,11,12 6 to 12 hours for EC, and 10 to 24 hours for microglia6 induced 50% to 80% death for each cell type. Cocultures were subjected to OGD for 8 hours, then 5.5 mmol/L glucose was added and the cultures returned to the normoxic incubator (ie, reperfusion) for 24 hours. Cell death was quantified by staining with trypan blue and cell counting, expressing stained cells as a percent of total number of cells or assay of released lactate dehydrogenase (LDH),12,13 expressed as a percentage of the total LDH released after freeze-thaw (100%).

Superoxide and Hydrogen Peroxide Assays
Superoxide was estimated using iodonitrotetrazolium violet.14 Absorbance at 490 nm was read on a UVmax platereader (Molecular Devices). Optical densities were normalized to the amount of protein in sister cultures treated identically until cell collection.

Hydrogen peroxide (H2O2) levels were determined using Amplex Red (A22180; Molecular Probes) according to manufacturer instructions. The assay uses a 1-step reagent with horseradish peroxidase to produce a red fluorescent product. H2O2 concentrations were calculated using a standard curve (0 to 20 µmol/L) and normalized to the protein concentration in each culture.

Cultures were fixed in 100% acetone for 10 minutes for EC markers or 4% paraformaldehyde at room temperature for 20 minutes for all other markers, blocked in normal serum, and immunostained.15 Primary antibodies used were: ECs, purified rat anti-mouse anti-CD31 antibody (557355; BD Pharmingen); astrocytes, anti–glial fibrillary acid protein (GFAP) antibody (G3893; Sigma-Aldrich); fibroblasts, antifibronectin (MAB88904; Chemicon); and pericytes, anti–{alpha}2-smooth muscle actin (MAB1501; Chemicon). Microglia were identified using lectin staining by incubating in 10 µg/mL peroxidase-labeled Griffonia simplicifolia B4-isolectin (IB4).16 Brain sections stained with IB4 were counterstained with hematoxylin and eosin.

ELISA Assays
ELISA assays of culture supernatants used the OptEIA Kit 558874 (BD Pharmingen) to detect bound and free tumor necrosis factor-{alpha} (TNF-{alpha}). All samples were run in triplicate. Measurements were normalized to the amount of protein produced per 105 cells in the culture supernatants.

Drug Treatments
Neither minocycline nor apocynin was toxic to cultures at 200 nmol/L to 2 µmol/L for minocycline and 0.25 to 1.0 mmol/L for apocynin (data not shown). Intermediate concentrations of minocycline (400 nmol/L; Sigma) or apocynin (500 µmol/L; Fluka) were added to culture media at the onset of injury.

Experimental Stroke Model
Male C57/BL6 mice (Jackson Laboratories; Bar Harbor, Maine) weighing 25 to 30 g were anesthetized and subjected to transient middle cerebral artery occlusion (MCAO)12 using an uncoated monofilament suture for 2 hours. Mice were euthanized with an isoflurane overdose at 1 day. Mice (n=12) received 2 injections of 45 mg/kg minocycline HCl (Sigma) intraperitoneally at 30 minutes and 12 hours after MCAO17,18 or vehicle (n=9). Neurological deficits were assessed 24 hours after ischemia onset using a modified scale where 0 indicates no detectable deficit; 1, unable to extend the contralateral forelimb; 2, flexion of the contralateral forelimb; 3, mild circling to the contralateral side; 4, severe circling; and 5, falling to the contralateral side.19,20

Infarct Size and Hemorrhage Assessment
After euthanasia, brains were removed and cut into 2-mm coronal slices, and sections were inspected for gross hemorrhage21 and then immersed in 2,3,5-triphenyltetrazolium chloride (Sigma) at 37°C for 20 minutes. Infarct volume was determined using methods published previously.19 Afterward, brains were fixed and prepared for histochemistry.16

Detection of BBB Disruption
BBB permeability was evaluated by detection of extravasated Evans blue dye. A total of 100 µL of 4% Evans blue in PBS was infused via the tail vein 3 hours before euthanasia (n=6 per group). At the time of euthanasia, mice were anesthetized and transcardially perfused with ice-cold PBS. The volume of dye extravasation was determined by tracing the region of blue-stained tissue from coronal sections and normalized to the infarct volume to correct for smaller lesion sizes among treated animals. This method is highly correlated with a previously used spectrophotometric method (data not shown).22

ANOVA followed by Neuman–Keuls was used for studies involving >2 groups of normally distributed data, Student t test for studies involving 2 groups and nonparametric tests (Mann–Whitney) were applied when data were not normally distributed. Fisher exact test was applied to hemorrhage scores and mortality data. In vitro experiments were conducted in triplicate on cells from ≥3 separate dissections. Data were expressed as means±SE. Values of P<0.05 were considered significant.

* Results

Characterization of Primary Astrocytes, ECs, and Microglia Cultures
EC cultures are shown in Figure 1A and 1B. Immunostaining for von Willebrand factor indicates that the majority of cells are ECs (Figure 1B). Fibroblasts, pericytes, and microglia accounted for <5% of cells (data not shown). Representative EA cocultures were stained for GFAP (brown) to identify astrocytes (Figure 1C). A representative triculture (Figure 1D) shows phase-bright microglia on a bed of astrocytes and ECs by phase contrast. Microglia are identified by staining with isolectin IB4 (Figure 1E).
Figure 1

Figure 1. Primary cell cultures. A, ECs viewed under phase contrast microscopy. B, EC cultures immunostained with von Willebrand factor show that the majority of the cells are ECs. C, A representative EA coculture with astrocytes immunostained for GFAP plated on top of a layer of ECs. D, A representative triculture under phase contrast microscopy showing ECs and astrocytes with microglia appearing as phase bright cells on top. E, A triculture with microglia identified by positive staining with isolectin B4.

Microglia Increase Susceptibility to OGD
The addition of astrocytes to EC cultures somewhat increased susceptibility to OGD compared with ECs alone, although this was not statistically significant (Figure 2A and 2B). No cell death was observed in microglial cultures after 8-hour OGD (data not shown). When EA cocultures were subjected to 8-hour OGD and 24-hour reperfusion, &30% cell death occurred (Figure 2A through 2D). When microglia were added to the cocultures (EAM), cell death nearly doubled (60%; Figure 2A through 2D). Minocycline, used here to inhibit microglial activation, reduced the microglia-induced injury after OGD in tricultures (Figure 2C and 2D) to levels similar to EA cocultures but did not protect EC or EA cocultures. Apocynin reduced cell death in EAM tricultures to a level similar to that in untreated EA cultures subjected to OGD (Figure 2C).
Figure 2

Figure 2. Microglia potentiate OGD-induced cell death of EA cocultures, and minocycline and apocynin block this potentiation. Cell death was assessed using LDH released into the media (A and C) or by cell counting after trypan blue staining (B). The addition of astrocytes (EA) to EC cultures (E) somewhat increased susceptibility to OGD (NS). The addition of microglia (EAM) approximately doubled the extent of cell death compared with EA. B, Trypan blue staining revealed similar results (*P<0.05 vs EA; #P<0.001 vs E; n=10 to 12 cultures per condition). C, EA and EAM were subjected to 8-hour OGD followed by 24-hour reperfusion in the presence or absence of inhibitors. Minocycline (+Mi) reduced cell death to that of EA cocultures. Apocynin (+Apo) also prevented the microglial-induced exacerbation of EA death. (*P<0.01 vs EAM) D, Cultures were stained with Trypan blue after OGD and reperfusion. Photomicrographs of EA cocultures show limited cell death after 8-hour OGD. In the presence of microglia (EAM), the amount of injury is increased. Treatment of EAM with minocycline (+400 nmol/L Mi) reduced the extent of cell death to levels similar to that of EA.

OGD Increases Superoxide, H2O2, and TNF-{alpha} in Activated Microglia
Superoxide and H2O2 were assayed after only 4-hour OGD followed by 3-hour reperfusion in EAM tricultures to avoid the confound of having a large number of cells already lysed. Superoxide and H2O2 were increased over basal levels (P<0.05). Minocycline and apocynin reduced superoxide after OGD/reperfusion compared with untreated controls (P<0.05; Figure 3A), and H2O2 was also reduced by apocynin (Figure 3B). TNF-{alpha} levels in uninjured microglial cultures were below the limits of detection, indicating that these cells were not activated but increased markedly (to 1500 pg/mL/105 cells) after 8-hour OGD and 16-hour reperfusion. Neither minocycline nor apocynin significantly reduced TNF-{alpha} production from this level (data not shown).
Figure 3

Figure 3. Superoxide and H2O2 increase after OGD. A, Superoxide levels were significantly increased after 4-hour OGD and further after 3-hour reperfusion in tricultures, a time point when cells are largely intact. Minocycline (Mi) and apocynin (Apo) reduced superoxide to a similar extent during OGD (#P<0.05; *P<0.01; **P<0.001 vs control injury [Con]). Sh indicates sham-washed no injury controls. B, H2O2 increased after OGD and was reduced by Apo treatment (*P<0.05 vs Sh; **P<0.05 vs Con).

Minocycline Improves Neurological Outcome and Reduces BBB Disruption, Hemorrhage, and Perivascular Microglial Accumulation In Vivo
After MCAO and reperfusion, mice treated with minocycline had significantly smaller infarcts and better neurological scores than vehicle-treated mice (Figure 4). Furthermore, mortality was no different between groups (minocycline 2 of 12 died; vehicle 2 of 9 died; NS). Minocycline reduced Evan’s Blue extravasation (Figure 5A and 5B). Because minocycline may lessen the extent of BBB disruption by reducing infarct size, we corrected for this potential confound by expressing the extent of BBB disruption relative to the infarct size and found that minocycline still reduced the proportionate amount of Evan’s Blue dye extravasation (Figure 5C). Minocycline reduced the occurrence of hemorrhagic transformation, assessed by scoring each brain for macroscopic hemorrhage at 24 hours,21 from 70% of animals in the control group to only 17% in the treated group (P<0.01; Figure 6A and 6B). Lectin histochemistry to identify microglia/monocytes showed that cerebral vessels in cortex within the ischemic core were surrounded by microglia (Figure 6C). In contrast, vessels in comparable ischemic brain regions in a minocycline-0treated animal showed fewer microglia/monocytes associated with vessels (Figure 6D).
Figure 4

Figure 4. Minocycline lessens infarct size and neurological deficits after experimental stroke. Infarct volume (A) and neurological scores (B) were improved by minocycline treatment (Mi) at 1 day (n=10 Mi; n=7 Con; *P<0.05; ***P<0.001 vs Con).
Figure 5

Figure 5. Minocycline reduces BBB disruption. A, Representative sections of animals perfused with Evan’s Blue dye. Extravasation is observed in a vehicle-treated, control animal (Con), but this is markedly reduced in an animal given minocycline (Mi). B, The total volumes of Evan’s Blue dye extravasation were reduced by minocycline as well as the relative proportion of extravasation normalized to the infarct volume (C). **P<0.01; ***P<0.001.
Figure 6

Figure 6. Minocycline reduces the incidence of hemorrhage after MCAO. Brains were sectioned and inspected for gross hemorrhage 24 hours after ischemia onset. The majority of control animals (70%) had some amount of hemorrhage (A), but most minocycline-treated animals (83%) had no hemorrhage (B). Lectin histochemistry shows that perivascular microglia/monocytes are abundant in the vicinity of cerebral vessels within ischemic cortex in a vehicle treated animal (C) but are reduced by minocycline treatment (D). Arrows indicate microglia; arrowheads, cerebral vessels. Bar=25 µm.


The BBB consists of a continuous capillary endothelium with tight junctions between cells, surrounded by astrocytes and perivascular microglia. This barrier restricts access of molecules and cells into the brain. Its disruption can lead to vasogenic edema and central nervous system pathology in conditions such as stroke and brain tumors. Hemorrhagic transformation and edema after ischemic stroke are thought to occur in the setting of BBB disruption and often lead to worsening of neurologic damage. Free radicals decrease EC electrical resistance and increase permeability.23 Astrocytes strengthen the BBB, increasing electrical resistance almost 2-fold.24–26 The role of other cellular constituents, such as microglia, has not been studied extensively. It is now appreciated that excessive or improperly regulated inflammatory responses may contribute to damage.2 Microglia are stimulated within hours after ischemia onset,27,28 followed by upregulation of a variety of inflammatory factors. Microglia can generate similar substances under ischemia-like3,29 and ischemic30 conditions. Lynch et al31 correlated microglial activation to BBB disruption in a model of 3-chlorpropanediol toxicity. Although they showed increased complement and inflammatory cytokine expression in microglia where BBB disruption occurred, their study did not prove a direct detrimental role. Using a model system in which microglia can be systematically added, we demonstrate for the first time that microglia clearly worsen ischemia-like injury to components of the BBB (ie, astrocytes and ECs).

Minocycline, a member of the tetracycline antibiotic family, will inhibit microglial activation and protect cultured neurons from excitotoxic insults by preventing microglial generation of glutamate, IL-1ß and NO.32 Minocycline also limits brain injury in experimental models of focal17 and global18 ischemia and Parkinson’s disease.33 It has also been associated with decreased BBB disruption after intranigral lipopolysaccharide injection33 and collagenase-induced intracerebral hemorrhage.34 We observed that inhibiting microglial activation with minocycline limited ischemia-like damage in an in vitro BBB model. We also found that minocycline reduced the release of superoxide after OGD but did not prevent TNF-{alpha} release by microglia. In vivo, we reproduced previous observations that minocycline improved neurological outcome after experimental stroke.17 We now show that minocycline reduces BBB disruption, findings consistent with our in vitro observations. Furthermore, vascular and perivascular microglia were decreased by minocycline treatment, consistent with a possible detrimental role in BBB integrity. Together, these findings suggest that activated microglia potentiate injury to BBB elements, likely at least in part by superoxide generation. We also demonstrate parallel observations at the in vivo level, where inhibiting microglial activation led to decreased BBB disruption and hemorrhage.

The anti-inflammatory properties of minocycline are thought to be through its ability to inhibit p38 mitogen-activated protein kinase32,35 and matrix metalloproteinase-9.36 Although minocycline can inhibit other aspects of cell death,37 we know of no other agent with a more selective profile for microglia. In support of minocycline as a relatively specific inhibitor of microglial activation, we observed complete reversal of microglia-exacerbated injury to ECs and astrocytes and reduced numbers of perivascular microglia/ monocytes.

Leukocytes and microglia secrete superoxide using NADPH oxidase as a defense against microorganisms.7,38 Although largely found in inflammatory cells, some reports suggest NADPH oxidase may also generate superoxide in neurons and astrocytes.39,40 After experimental stroke and meningitis, NADPH oxidase is found primarily in microglia and peripheral inflammatory cells.38 We show that blocking superoxide generation using apocynin also prevented microglia-induced exacerbation of cell death and superoxide generation. Other microglial factors may also potentiate injury and superoxide may upregulate additional damaging factors, which would be suppressed by inhibiting NADPH oxidase. Furthermore, neuroprotective factors produced by microglia could be downregulated by OGD.

In conclusion, microglia potentiate damage to components of the BBB under ischemia-like conditions, and this worsened injury is prevented by inhibiting microglial activation and generation of superoxide. Minocycline reduces BBB disruption and hemorrhage in experimental ischemic stroke. Thrombolysis, although indicated for the treatment of acute ischemic stroke at the clinical level, is still infrequently used because of the short temporal therapeutic window and risk of hemorrhage.41 Although further studies are needed to clarify the role of minocycline in reducing thrombolytic-induced cerebral hemorrhage, these data suggest a novel reason to target microglia for treatment of cerebral ischemia.

*    Acknowledgments

This work was supported by National Institutes of Health grants R01 NS40516 (M.A.Y.), P50 NS14543, and P01 NS37520 (R.G.G., M.A.Y.), and R01 GM49831 (R.G.G.). The authors thank David Schaal for editorial assistance, Elizabeth Hoyte for preparing the figures, and Maya Koike and Liping Liu for expert technical assistance.

Received August 9, 2005; revision received September 29, 2005; accepted November 8, 2005.

*    References

  1. Gehrmann J, Matsumoto Y, Kreutzberg GW. Microglia: intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev. 1995; 20: 269–287.[CrossRef][Medline] [Order article via Infotrieve]
  2. Stoll G, Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol. 1999; 58: 233–247.[CrossRef][Medline] [Order article via Infotrieve]
  3. Flavin MP, Ho LT. Propentofylline protects neurons in culture from death triggered by macrophage or microglial secretory products. J Neurosci Res. 1999; 56: 54–59.[CrossRef][Medline] [Order article via Infotrieve]
  4. Flavin MP, Coughlin K, Ho LT. Soluble macrophage factors trigger apoptosis in cultured hippocampal neurons. Neuroscience. 1997; 80: 437–448.[CrossRef][Medline] [Order article via Infotrieve]
  5. Lyons SA, Kettenmann H. Oligodendrocytes and microglia are selectively vulnerable to combined hypoxia and hypoglycemia injury in vitro. J Cereb Blood Flow Metab. 1998; 18: 521–530.[CrossRef][Medline] [Order article via Infotrieve]
  6. Yenari MA, Giffard RG. Ischemic vulnerability of primary murine microglial cultures. Neurosci Lett. 2001; 298: 5–8.[CrossRef][Medline] [Order article via Infotrieve]
  7. Sankarapandi S, Zweier JL, Mukherjee G, Quinn MT, Huso DL. Measurement and characterization of superoxide generation in microglial cells: Evidence for an NADPH oxidase-dependent pathway. Arch Biochem Biophys. 1998; 353: 312–321.[CrossRef][Medline] [Order article via Infotrieve]
  8. Xu J, He L, Ahmed SH, Chen SW, Goldberg MP, Beckman JS, Hsu CY. Oxygen-glucose deprivation induces inducible nitric oxide synthase and nitrotyrosine expression in cerebral endothelial cells. Stroke. 2000; 31: 1744–1751.[Abstract/Free Full Text]
  9. Gobbel GT, Chan TY, Gregory GA, Chan PH. Response of cerebral endothelial cells to hypoxia: modification by fructose-1,6-bisphosphate but not glutamate receptor antagonists. Brain Res. 1994; 653: 23–30.[CrossRef][Medline] [Order article via Infotrieve]
  10. Dugan LL, Bruno VM, Amagasu SM, Giffard RG. Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity. J Neurosci. 1995; 15: 4545–4555.[Abstract]
  11. Papadopoulos MC, Koumenis IL, Yuan TY, Giffard RG. Increasing vulnerability of astrocytes to oxidative injury with age despite constant antioxidant defenses. Neuroscience. 1998; 82: 915–925.[CrossRef][Medline] [Order article via Infotrieve]
  12. Lee JE, Yenari MA, Sun GH, Xu L, Emond MR, Cheng D, Steinberg GK, Giffard RG. Differential neuroprotection from human heat shock protein 70 overexpression in in vitro and in vivo models of ischemia and ischemia-like conditions. Exp Neurol. 2001; 170: 129–139.[CrossRef][Medline] [Order article via Infotrieve]
  13. Koh JY, Choi DW. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods. 1987; 20: 83–90.[CrossRef][Medline] [Order article via Infotrieve]
  14. Papadopoulos MC, Koumenis IL, Xu L, Giffard RG. Potentiation of murine astrocyte antioxidant defence by bcl-2: protection in part reflects elevated glutathione levels. Eur J Neurosci. 1998; 10: 1252–1260.[CrossRef][Medline] [Order article via Infotrieve]
  15. Qiao Y, Ouyang YB, Giffard RG. Overexpression of hdj-2 protects astrocytes from ischemia-like injury and reduces redistribution of ubiquitin staining in vitro. J Cereb Blood Flow Metab. 2003; 23: 1113–1116.[Medline] [Order article via Infotrieve]
  16. Wang GJ, Deng HY, Maier CM, Sun GH, Yenari MA. Mild hypothermia reduces ICAM-1 expression, neutrophil infiltration and microglia/monocyte accumulation following experimental stroke. Neuroscience. 2002; 114: 1081–1090.[Medline] [Order article via Infotrieve]
  17. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A. 1999; 96: 13496–13500.[Abstract/Free Full Text]
  18. Yrjänheikki J, Keinänen R, Pellikka M, Hökfelt T, Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A. 1998; 95: 15769–15774.[Abstract/Free Full Text]
  19. Maier CM, Sun GH, Kunis D, Yenari MA, Steinberg GK. Delayed induction and long-term effects of mild hypothermia in a focal model of transient cerebral ischemia: Neurological outcome and infarct size. J Neurosurg. 2001; 94: 90–96.[Medline] [Order article via Infotrieve]
  20. Yang G, Chan PH, Chen J, Carlson E, Chen SF, Weinstein P, Epstein CJ, Kamii H. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke. 1994; 25: 165–170.[Abstract]
  21. Yenari MA, de Crespigny A, Palmer JT, Roberts S, Schrier SL, Albers GW, Moseley ME, Steinberg GK. Improved perfusion with rt-pa and hirulog in a rabbit model of embolic stroke. J Cereb Blood Flow Metab. 1997; 17: 401–411.[CrossRef][Medline] [Order article via Infotrieve]
  22. Belayev L, Busto R, Zhao W, Ginsberg MD. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res. 1996; 739: 88–96.[CrossRef][Medline] [Order article via Infotrieve]
  23. Imaizumi S, Kondo T, Deli MA, Gobbel G, Joo F, Epstein CJ, Yoshimoto T, Chan PH. The influence of oxygen free radicals on the permeability of the monolayer of cultured brain endothelial cells. Neurochem Int. 1996; 29: 205–211.[CrossRef][Medline] [Order article via Infotrieve]
  24. Fischer S, Wobben M, Kleinstuck J, Renz D, Schaper W. Effect of astroglial cells on hypoxia-induced permeability in PBMEC cells. Am J Physiol Cell Physiol. 2000; 279: C935–C944.[Abstract/Free Full Text]
  25. Kondo T, Kinouchi H, Kawase M, Yoshimoto T. Astroglial cells inhibit the increasing permeability of brain endothelial cell monolayer following hypoxia/reoxygenation. Neurosci Lett. 1996; 208: 101–104.[CrossRef][Medline] [Order article via Infotrieve]
  26. Gaillard PJ, Voorwinden LH, Nielsen JL, Ivanov A, Atsumi R, Engman H, Ringbom C, de Boer AG, Breimer DD. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a coculture of brain capillary endothelial cells and astrocytes. Eur J Pharm Sci. 2001; 12: 215–222.[CrossRef][Medline] [Order article via Infotrieve]
  27. Morioka T, Kalehua AN, Streit WJ. Characterization of microglial reaction after middle cerebral artery occlusion in rat brain. J Comp Neurol. 1993; 327: 123–132.[CrossRef][Medline] [Order article via Infotrieve]
  28. Davies CA, Loddick SA, Stroemer RP, Hunt J, Rothwell NJ. An integrated analysis of the progression of cell responses induced by permanent focal middle cerebral artery occlusion in the rat. Exp Neurol. 1998; 154: 199–212.[CrossRef][Medline] [Order article via Infotrieve]
  29. Flavin MP, Zhao G, Ho LT. Microglial tissue plasminogen activator (tpa) triggers neuronal apoptosis in vitro. Glia. 2000; 29: 347–354.[CrossRef][Medline] [Order article via Infotrieve]
  30. Han HS, Qiao Y, Karabiyikoglu M, Giffard RG, Yenari MA. Influence of mild hypothermia on inducible nitric oxide synthase expression and reactive nitrogen production in experimental stroke and inflammation. J Neurosci. 2002; 22: 3921–3928.[Abstract/Free Full Text]
  31. Lynch NJ, Willis CL, Nolan CC, Roscher S, Fowler MJ, Weihe E, Ray DE, Schwaeble WJ. Microglial activation and increased synthesis of complement component c1q precedes blood-brain barrier dysfunction in rats. Mol Immunol. 2004; 40: 709–716.[CrossRef][Medline] [Order article via Infotrieve]
  32. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci. 2001; 21: 2580–2588.[Abstract/Free Full Text]
  33. Tomas-Camardiel M, Rite I, Herrera AJ, de Pablos RM, Cano J, Machado A, Venero JL. Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system. Neurobiol Dis. 2004; 16: 190–201.[CrossRef][Medline] [Order article via Infotrieve]
  34. Power C, Henry S, Del Bigio MR, Larsen PH, Corbett D, Imai Y, Yong VW, Peeling J. Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann Neurol. 2003; 53: 731–742.[CrossRef][Medline] [Order article via Infotrieve]
  35. Tikka TM, Koistinaho JE. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol. 2001; 166: 7527–7533.[Abstract/Free Full Text]
  36. Koistinaho M, Malm TM, Kettunen MI, Goldsteins G, Starckx S, Kauppinen RA, Opdenakker G, Koistinaho J. Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice. J Cereb Blood Flow Metab. 2005; 25: 460–467.[CrossRef][Medline] [Order article via Infotrieve]
  37. Friedlander RM. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med. 2003; 348: 1365–1375.[Free Full Text]
  38. Green SP, Cairns B, Rae J, Errett-Baroncini C, Hongo JA, Erickson RW, Curnutte JT. Induction of gp91-phox, a component of the phagocyte NADPH oxidase, in microglial cells during central nervous system inflammation. J Cereb Blood Flow Metab. 2001; 21: 374–384.[CrossRef][Medline] [Order article via Infotrieve]
  39. Noh KM, Koh JY. Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. J Neurosci. 2000; 20: RC111.
  40. Hori O, Matsumoto M, Maeda Y, Ueda H, Ohtsuki T, Stern DM, Kinoshita T, Ogawa S, Kamada T. Metabolic and biosynthetic alterations in cultured astrocytes exposed to hypoxia/reoxygenation. J Neurochem. 1994; 62: 1489–1495.[Medline] [Order article via Infotrieve]
  41. Morgenstern LB, Staub L, Chan W, Wein TH, Bartholomew LK, King M, Felberg RA, Burgin WS, Groff J, Hickenbottom SL, Saldin K, Demchuk AM, Kalra A, Dhingra A, Grotta JC. Improving delivery of acute stroke therapy: the TLL Temple Foundation Stroke Project. Stroke. 2002; 33: 160–166.[Abstract/Free Full Text]


Entry filed under: Documentos en Inglés.

Neonatal MRI to Predict Neurodevelopmental Outcomes in Preterm Infants Cerebral Aneurysms


Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión /  Cambiar )

Google+ photo

Estás comentando usando tu cuenta de Google+. Cerrar sesión /  Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión /  Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión /  Cambiar )


Conectando a %s

Trackback this post  |  Subscribe to the comments via RSS Feed

La Fundación Anna Vázquez es una entidad sin fines de lucro aprobada legalmente según Personería Jurídica Nº 361/07 CUIT30-71028256-7 Tiene como misión atender las necesidades del niño enfermo de cáncer cerebral y su familia a lo largo de las distintas etapas de la enfermedad. IMPORTANTE: Este es un SITIO DE DIVULGACIÓN CIENTÍFICA, por lo cual contiene imágenes médicas que pueden alterar su sensibilidad
Los artículos puestos a consideración aquí son de carácter netamente informativo y de ninguna manera deben tomarse como consejo profesional, visite a su médico para obtener diagnóstico y tratamiento. Las expresiones aquí vertidas en los comentarios o en los artículos recopilados, son exclusiva responsabilidad de sus autores y no concuerdan necesariamente con las opiniones de quienes formamos la Fundación.

Estadísticas del Web Site de la Fundación Anna Vázquez

  • 12,860,355 personas ya nos visitaron...
junio 2007
« May   Jul »

Archivos de la Fundación Anna Vázquez

A %d blogueros les gusta esto: